gallium has been researched along with Lymphoma, Follicular in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 5 (45.45) | 2.80 |
Authors | Studies |
---|---|
Feng, J; Guo, W; Hong, X; Kinkolykh, A; Knapp, A; Li, J; Lin, T; Shi, Y; Song, Y; Wu, G; Zhang, Q | 1 |
Burke, JM; Diefenbach, C; Ferrari, S; Gilbertson, M; Khan, C; Nielsen, TG; Raval, A; Sellam, G; Sharman, JP; Shivhare, M; Tani, M; Ujjani, C; Vitolo, U; Younes, A; Yuen, S | 1 |
Casulo, C; Herold, M; Hiddemann, W; Iyengar, S; Knapp, A; Launonen, A; Marcus, RE; Mir, F; Nielsen, TG; Seymour, JF | 1 |
Kotake, Y; Mukai, J; Nishimura, M; Okuda, H; Sakamoto, R; Takehara, R; Wada, Y; Yamada, K | 1 |
Mikhaeel, NG | 1 |
Friedberg, JW | 1 |
Luminari, S | 1 |
Adams, HJA; Kwee, TC | 1 |
Barrington, SF; Meignan, M; Trotman, J | 1 |
Haubold, U; Koppenhagen, K | 1 |
Berelowitz, M; Blake, KC | 1 |
2 trial(s) available for gallium and Lymphoma, Follicular
Article | Year |
---|---|
Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM study.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Gallium; Humans; Lymphoma, Follicular; Rituximab | 2021 |
Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Gallium; Humans; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Risk Factors; Rituximab | 2023 |
9 other study(ies) available for gallium and Lymphoma, Follicular
Article | Year |
---|---|
Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Gallium; Humans; Lymphoma, Follicular; Rituximab | 2022 |
[Modified Premedication of Infusion Reaction with Obinutuzumab Therapy].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Gallium; Humans; Lymphoma, Follicular; Premedication | 2023 |
Hotter is not more aggressive: baseline SUVmax in FL.
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography | 2020 |
Progress in Advanced-Stage Follicular Lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Gallium; Humans; Lymphoma, Follicular; Rituximab | 2018 |
Personalised approach in follicular lymphoma.
Topics: Gallium; Humans; Immunotherapy; Lymphoma, Follicular; Prognosis | 2018 |
Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply.
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
[Tumor scintigraphy using 67 Ga citrate].
Topics: Breast Neoplasms; Carcinoma; Citrates; Female; Gallium; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Melanoma; Neoplasms; Radionuclide Imaging | 1972 |
67 Gallium in the detection and localization of tumours.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Citrates; Female; Gallium; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methods; Neoplasms; Radioisotopes; Radionuclide Imaging; Sarcoma | 1971 |